Scientists Restore Memory in Mice by Blocking a Single Alzheimer's Protein
Blocking the protein PTP1B boosted memory and cleared brain plaque in mice, with potential links to diabetes and obesity treatment.
785 articles
Blocking the protein PTP1B boosted memory and cleared brain plaque in mice, with potential links to diabetes and obesity treatment.
A carcinogen found in recalled meds like Zantac is present in higher amounts in a single serving of grilled chicken.
The FDA proposes removing semaglutide, tirzepatide, and liraglutide from the compounding bulks list, restricting cheaper alternatives.
Auvelity becomes the first non-antipsychotic FDA-approved treatment for agitation in Alzheimer's dementia, offering a new option for patients and caregivers.
The FDA proposes removing semaglutide, tirzepatide, and liraglutide from compounding lists, tightening access to cheaper GLP-1 alternatives.
A roundup of gastroenterology research covers AI cancer detection, IBD drug safety, GLP-1 combos for liver disease, and more.
A redesigned CRISPR system targets the chromosomal root cause of Down syndrome, opening new doors for genetic disease intervention.
Epicrispr's GEMS platform silences disease genes epigenetically โ reversibly and safely โ with a single viral vector, targeting FSHD and beyond.
A new perspective outlines how stem cells, bioprinted organs, and cross-species genes could replace โ not just repair โ aging biology.
Sana Biotechnology and Mayo Clinic are advancing SC451, a cell therapy that may restore natural insulin production without immunosuppression.
AT7687 blocks fat storage signals rather than suppressing hunger, showing early safety wins and metabolic benefits in first-in-human data.
Rafael Holdings licenses MIT patent for cyclodextrin therapy targeting cholesterol transport failure in ApoE4-linked Alzheimer's disease.